Question 1

Who are the top researchers at Genecast (China)?

Accepted Answer

Ranked on the quality score, Ji He, Huaibo Sun and Weizhi Chen lead among researchers whose main affiliation is Genecast (China).

Question 2

What are the most cited papers from Genecast (China)?

Accepted Answer

The most cited paper from Genecast (China) is "Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer" (Qingzhu Jia, Wei Wu, Yuqi Wang et al., 2018), with 549 citations. Next come "Tumor neoantigens: from basic research to clinical applications" (404) and "Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer: A prospective, single-arm, phase II study (TD-NICE)" (243).

Question 3

Which research topics does Genecast (China) publish most on?

Accepted Answer

By volume in 2022-now: Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations and Lung Cancer Research Studies.

Question 4

Which keywords describe research at Genecast (China)?

Accepted Answer

By fractional works in 2022-now, weighted toward what it does more of than the world: Targeted Therapy, Chemotherapy, Tumor Microenvironment, Clinical Trials, Cancer Genomics, Mutational Signatures, Immune Checkpoint Blockade and PD-1 and PD-L1.

Question 5

Which fields of science does Genecast (China) work in?

Accepted Answer

In 2022-now, 71% of research at Genecast (China) is in Health Sciences, 28% in Life Sciences. Its largest fields are Medicine (71%), Biochemistry, Genetics and Molecular Biology (25%), Immunology and Microbiology (3%). It does 2.6× the world's share of Health Sciences.

Question 6

Is Genecast (China)'s research output growing?

Accepted Answer

Output in 2022-2025 was 11% lower than in 2018-2021.